Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does TEMOZOLOMIDE Cause Neutrophil count increased? 10 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 10 reports of Neutrophil count increased have been filed in association with TEMOZOLOMIDE (TEMOZOLOMIDE). This represents 0.1% of all adverse event reports for TEMOZOLOMIDE.

10
Reports of Neutrophil count increased with TEMOZOLOMIDE
0.1%
of all TEMOZOLOMIDE reports
5
Deaths
6
Hospitalizations

How Dangerous Is Neutrophil count increased From TEMOZOLOMIDE?

Of the 10 reports, 5 (50.0%) resulted in death, 6 (60.0%) required hospitalization, and 3 (30.0%) were considered life-threatening.

Is Neutrophil count increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for TEMOZOLOMIDE. However, 10 reports have been filed with the FAERS database.

What Other Side Effects Does TEMOZOLOMIDE Cause?

Disease progression (1,562) Death (1,403) Off label use (1,357) Product use in unapproved indication (1,353) Thrombocytopenia (1,300) Drug ineffective (1,131) Nausea (1,071) Neutropenia (809) Malignant neoplasm progression (779) Fatigue (766)

What Other Drugs Cause Neutrophil count increased?

CLOZAPINE (3,125) PREDNISONE (365) RITUXIMAB (346) CLOZARIL (224) OLANZAPINE (220) METHYLPREDNISOLONE (202) CYCLOPHOSPHAMIDE (177) ADALIMUMAB (175) ALEMTUZUMAB (171) PACLITAXEL (159)

Which TEMOZOLOMIDE Alternatives Have Lower Neutrophil count increased Risk?

TEMOZOLOMIDE vs TEMSIROLIMUS TEMOZOLOMIDE vs TENAMFETAMINE TEMOZOLOMIDE vs TENAPANOR TEMOZOLOMIDE vs TENECTEPLASE TEMOZOLOMIDE vs TENELIGLIPTIN

Related Pages

TEMOZOLOMIDE Full Profile All Neutrophil count increased Reports All Drugs Causing Neutrophil count increased TEMOZOLOMIDE Demographics